Skip to content

Neogen

US · NEOG #2579 by market cap Listed 1970
10.55 -0.30 -2.77%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Rating change
    Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Raises Target Price to $13
    Market Newswire · 2026/8/3
  • Company notice
    Neogen | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Ranalli Tamara A.
    SEC · 2026/1/29
  • Neogen Q1 Adj. EPS $0.08 Beats $(0.07) Estimate, Sales $222.800M Beat $208.175M Estimate
    Benzinga · 2026/10/7
  • Rating change
    Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Raises Target Price to $12
    Market Newswire · 2026/1/9
  • Rating change
    Analysts' Opinions Are Mixed on These Healthcare Stocks: Neogen (NEOG), Larimar Therapeutics (LRMR) and Sagimet Biosciences, Inc. Class A (SGMT)
    TipRanks · 2026/9/28
  • Piper Sandler Maintains Neogen(NEOG.US) With Buy Rating, Maintains Target Price $14
    Market Newswire · 2026/10/7
  • Company notice
    Neogen | 3: Initial statement of beneficial ownership of securities-Officer Ranalli Tamara A.
    SEC · 2026/1/26
  • Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Raises Target Price to $14
    Market Newswire · 2026/9/30
  • Rating change
    Analysts Conflicted on These Healthcare Names: Neogen (NEOG), Pfizer (PFE) and Hinge Health, Inc. Class A (HNGE)
    TipRanks · 2026/7/30
  • Rating change
    Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Maintains Target Price $12
    Market Newswire · 2026/7/31
  • Rating change
    Piper Sandler Upgrades Neogen(NEOG.US) to Buy Rating, Raises Target Price to $14
    Market Newswire · 2026/8/26
  • Company notice
    Neogen | 4: Statement of changes in beneficial ownership of securities-Officer Naemura David H.
    SEC · 2025/12/3
  • Rating change
    CJS Securities Upgrades Neogen(NEOG.US) to Buy Rating, Maintains Target Price $10
    Market Newswire · 2025/12/10
  • Company notice
    Neogen | 4: Statement of changes in beneficial ownership of securities-Officer Naemura David H.
    SEC · 2025/10/29
  • Rating change
    Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Raises Target Price to $6.5
    Market Newswire · 2025/10/16
  • William Blair Maintains Neogen(NEOG.US) With Hold Rating
    Market Newswire · 2026/9/28
  • Company notice
    Neogen | 4: Statement of changes in beneficial ownership of securities-Officer Ranalli Tamara A.
    SEC · 2026/1/26
  • Rating change
    Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Raises Target Price to $10
    Market Newswire · 2026/1/13
  • Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Maintains Target Price $14
    Market Newswire · 2026/10/20
  • Rating change
    Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Cuts Target Price to $8
    Market Newswire · 2025/10/10
  • Rating change
    CJS Securities Initiates Neogen(NEOG.US) With Hold Rating, Announces Target Price $10
    Market Newswire · 2025/9/29
  • Rating change
    Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Maintains Target Price $5
    Market Newswire · 2025/8/4
  • Piper Sandler Maintains Neogen(NEOG.US) With Buy Rating, Maintains Target Price $14
    Market Newswire · 2026/9/15

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Neogen discussion 0 comments

Add a comment